SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001144204-12-034225
Filing Date
2012-06-11
Accepted
2012-06-11 16:25:17
Documents
10
Period of Report
2012-04-30
Filing Date Changed
2012-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v315454_10q.htm 10-Q 618031
2 EXHIBIT 31.1 v315454_ex31-1.htm EX-31.1 9481
3 EXHIBIT 31.2 v315454_ex31-2.htm EX-31.2 9518
4 EXHIBIT 32 v315454_ex32.htm EX-32 4862
  Complete submission text file 0001144204-12-034225.txt   2501267

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnbt-20120430.xml EX-101.INS 231931
6 XBRL TAXONOMY EXTENSION SCHEMA gnbt-20120430.xsd EX-101.SCH 20130
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnbt-20120430_cal.xml EX-101.CAL 48876
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnbt-20120430_def.xml EX-101.DEF 81382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnbt-20120430_lab.xml EX-101.LAB 190836
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnbt-20120430_pre.xml EX-101.PRE 107295
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 12900777
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1